{"id":"https://openalex.org/W4367304403","doi":"https://doi.org/10.1212/wnl.0000000000202904","title":"Subgroup outcomes from RAISE: A randomized, Phase 3 trial of zilucoplan in generalized myasthenia gravis (P1-5.006)","display_name":"Subgroup outcomes from RAISE: A randomized, Phase 3 trial of zilucoplan in generalized myasthenia gravis (P1-5.006)","publication_year":2023,"publication_date":"2023-04-25","ids":{"openalex":"https://openalex.org/W4367304403","doi":"https://doi.org/10.1212/wnl.0000000000202904"},"language":"en","primary_location":{"id":"doi:10.1212/wnl.0000000000202904","doi":"https://doi.org/10.1212/wnl.0000000000202904","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.0000000000202904","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5074064047","display_name":"Michael D. Weiss","orcid":"https://orcid.org/0000-0003-4064-1032","observed_orcids":["https://orcid.org/0000-0003-4064-1032"]},"institutions":[{"id":"https://openalex.org/I2801852214","display_name":"University of Washington Medical Center","ror":"https://ror.org/00wbzw723","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2801852214"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael D. Weiss","raw_affiliation_strings":["University of Washington Medical Center, Department of Neurology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Washington Medical Center, Department of Neurology","institution_ids":["https://openalex.org/I2801852214"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040141780","display_name":"Saskia Bresch","orcid":"https://orcid.org/0009-0004-3321-9014","observed_orcids":["https://orcid.org/0009-0004-3321-9014"]},"institutions":[{"id":"https://openalex.org/I3018988418","display_name":"Centre Hospitalier Universitaire de Nice","ror":"https://ror.org/05qsjq305","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I3018988418"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Saskia Bresch","raw_affiliation_strings":["Centre Hospitalier Universitaire de Nice"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Hospitalier Universitaire de Nice","institution_ids":["https://openalex.org/I3018988418"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019347256","display_name":"Miriam L. Freimer","orcid":"https://orcid.org/0000-0001-8282-764X","observed_orcids":["https://orcid.org/0000-0001-8282-764X"]},"institutions":[{"id":"https://openalex.org/I52357470","display_name":"The Ohio State University","ror":"https://ror.org/00rs6vg23","country_code":"US","type":"education","lineage":["https://openalex.org/I52357470"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Miriam Freimer","raw_affiliation_strings":["The Ohio State University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Ohio State University","institution_ids":["https://openalex.org/I52357470"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026363118","display_name":"Channa Hewamadduma","orcid":"https://orcid.org/0009-0009-6175-7027","observed_orcids":["https://orcid.org/0009-0009-6175-7027"]},"institutions":[{"id":"https://openalex.org/I91136226","display_name":"University of Sheffield","ror":"https://ror.org/05krs5044","country_code":"GB","type":"education","lineage":["https://openalex.org/I91136226"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Channa Hewamadduma","raw_affiliation_strings":["Department of Neuroscience, University of Sheffield"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neuroscience, University of Sheffield","institution_ids":["https://openalex.org/I91136226"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073644680","display_name":"Raul Juntas Morales","orcid":"https://orcid.org/0000-0003-2205-1741","observed_orcids":["https://orcid.org/0000-0003-2205-1741"]},"institutions":[{"id":"https://openalex.org/I4210127641","display_name":"Vall d'Hebron Hospital Universitari","ror":"https://ror.org/03ba28x55","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I157913058","https://openalex.org/I4210127641","https://openalex.org/I4210153292"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Raul Juntas-Morales","raw_affiliation_strings":["Vall d\u2019Hebron University Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vall d\u2019Hebron University Hospital","institution_ids":["https://openalex.org/I4210127641"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101696947","display_name":"Maria Isabel Leite","orcid":"https://orcid.org/0000-0003-4407-5066","observed_orcids":["https://orcid.org/0000-0003-4407-5066"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"M. Isabel Leite","raw_affiliation_strings":["Nuffield Department of Clinical Neurosciences - University of Oxford"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nuffield Department of Clinical Neurosciences - University of Oxford","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053767379","display_name":"Angelina Hatl\u00f8 Maniaol","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1281400175","display_name":"Oslo University Hospital","ror":"https://ror.org/00j9c2840","country_code":"NO","type":"healthcare","lineage":["https://openalex.org/I1281400175"]}],"countries":["NO"],"is_corresponding":false,"raw_author_name":"Angelina Maniaol","raw_affiliation_strings":["Department of Neurology, Oslo University Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Oslo University Hospital","institution_ids":["https://openalex.org/I1281400175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015694885","display_name":"Masayuki Masuda","orcid":"https://orcid.org/0000-0002-6175-8902","observed_orcids":["https://orcid.org/0000-0002-6175-8902"]},"institutions":[{"id":"https://openalex.org/I158929114","display_name":"Tokyo Medical University","ror":"https://ror.org/00k5j5c86","country_code":"JP","type":"education","lineage":["https://openalex.org/I158929114"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masayuki Masuda","raw_affiliation_strings":["Department of Neurology, Tokyo Medical University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Tokyo Medical University","institution_ids":["https://openalex.org/I158929114"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108261602","display_name":"Kumaraswamy Sivakumar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I138006243","display_name":"University of Arizona","ror":"https://ror.org/03m2x1q45","country_code":"US","type":"education","lineage":["https://openalex.org/I138006243"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kumaraswamy Sivakumar","raw_affiliation_strings":["University of Arizona, School of Medicine, Neuromuscular Clinic and Research Center"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Arizona, School of Medicine, Neuromuscular Clinic and Research Center","institution_ids":["https://openalex.org/I138006243"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039110340","display_name":"Ma\u0142gorzata Zajda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I268303160","display_name":"Medical University of Warsaw","ror":"https://ror.org/04p2y4s44","country_code":"PL","type":"education","lineage":["https://openalex.org/I268303160"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Malgorzata Zajda","raw_affiliation_strings":["Medical University of Warsaw"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical University of Warsaw","institution_ids":["https://openalex.org/I268303160"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091050492","display_name":"Babak Boroojerdi","orcid":"https://orcid.org/0000-0001-6708-8607","observed_orcids":["https://orcid.org/0000-0001-6708-8607"]},"institutions":[{"id":"https://openalex.org/I4210166732","display_name":"UCB Pharma (Germany)","ror":"https://ror.org/05pkeac16","country_code":"DE","type":"company","lineage":["https://openalex.org/I4210166732","https://openalex.org/I85722119"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Babak Boroojerdi","raw_affiliation_strings":["UCB Pharma, Monheim, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCB Pharma, Monheim, Germany","institution_ids":["https://openalex.org/I4210166732"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113844507","display_name":"Petra W. Duda","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Petra W. Duda","raw_affiliation_strings":["UCB Pharma, Cambridge, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCB Pharma, Cambridge, MA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024694073","display_name":"Guillemette de la Borderie","orcid":"https://orcid.org/0009-0000-6483-0925","observed_orcids":["https://orcid.org/0009-0000-6483-0925"]},"institutions":[{"id":"https://openalex.org/I85722119","display_name":"UCB Pharma (Belgium)","ror":"https://ror.org/01n029866","country_code":"BE","type":"company","lineage":["https://openalex.org/I85722119"]}],"countries":["BE"],"is_corresponding":false,"raw_author_name":"Guillemette De La Borderie","raw_affiliation_strings":["UCB Pharma, Brussels, Belgium"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCB Pharma, Brussels, Belgium","institution_ids":["https://openalex.org/I85722119"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036542525","display_name":"James F. Howard","orcid":"https://orcid.org/0000-0002-7136-8617","observed_orcids":["https://orcid.org/0000-0002-7136-8617"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James F. Howard","raw_affiliation_strings":["Department of Neurology, The University of North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, The University of North Carolina","institution_ids":["https://openalex.org/I114027177"]}]}],"institutions":[],"countries_distinct_count":9,"institutions_distinct_count":13,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.1616,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.40053741,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"100","issue":"17_supplement_2","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11271","display_name":"Myasthenia Gravis and Thymoma","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11271","display_name":"Myasthenia Gravis and Thymoma","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11735","display_name":"Peripheral Neuropathies and Disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/zilucoplan","display_name":"zilucoplan","score":0.9990000128746033},{"id":"https://openalex.org/keywords/generalized-myasthenia-gravis","display_name":"generalized myasthenia gravis","score":0.9940000176429749},{"id":"https://openalex.org/keywords/complement-c5-inhibition","display_name":"complement C5 inhibition","score":0.8619999885559082},{"id":"https://openalex.org/keywords/macrocyclic-peptides","display_name":"macrocyclic peptides","score":0.925000011920929},{"id":"https://openalex.org/keywords/mg-adl-score","display_name":"MG-ADL score","score":0.847000002861023},{"id":"https://openalex.org/keywords/disease-duration","display_name":"disease duration","score":0.9049999713897705},{"id":"https://openalex.org/keywords/subgroup-analysis","display_name":"subgroup analysis","score":0.9229999780654907},{"id":"https://openalex.org/keywords/raise-trial","display_name":"RAISE trial","score":0.824999988079071},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.3889999985694885},{"id":"https://openalex.org/keywords/safety-profile","display_name":"safety profile","score":0.7570000290870667},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.3790000081062317},{"id":"https://openalex.org/keywords/serious-adverse-events","display_name":"serious adverse events","score":0.5109999775886536},{"id":"https://openalex.org/keywords/medication-discontinuation","display_name":"drug discontinuation","score":0.3659999966621399}],"concepts":[{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7881479859352112},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7708207964897156},{"id":"https://openalex.org/C2778105408","wikidata":"https://www.wikidata.org/wiki/Q8285","display_name":"Myasthenia gravis","level":2,"score":0.7094687223434448},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.6880428194999695},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6365216970443726},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5100305676460266},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.39480510354042053},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1212/wnl.0000000000202904","doi":"https://doi.org/10.1212/wnl.0000000000202904","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.0000000000202904","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4389150853","https://openalex.org/W4386782769","https://openalex.org/W4365456974","https://openalex.org/W4410422168","https://openalex.org/W4415496288","https://openalex.org/W4394896461","https://openalex.org/W4394598639","https://openalex.org/W7164184485","https://openalex.org/W4392843954","https://openalex.org/W7115059703"],"abstract_inverted_index":{"Objective:":[0],"To":[1],"evaluate":[2],"the":[3,133,168,277,295,313,331,349,367,385,409,427,446,464,488,512,596,614,632,650,693,725,752,779,831,849,889,920,1009,1034,1059,1084,1108,1136,1163,1188],"efficacy":[4,56,118,258],"of":[5,36,42,106,207,261,279,297,315,333,351,369,387,411,429,448,466,490,514,531,542,553,564,598,616,634,652,663,675,695,717,727,744,754,771,781,798,812,833,851,868,891,922,943,969,990,1011,1036,1061,1086,1110,1138,1165,1190,1229,1239,1251,1263,1278,1289,1305,1318,1330,1358],"zilucoplan":[6,107,160,174,234,252],"in":[7,47,54,68,77,125,171,180,256,276,294,312,330,348,366,384,408,426,445,463,487,511,595,613,631,649,692,724,751,778,830,848,888,919,975,999,1008,1033,1058,1083,1107,1135,1162,1187,1205,1213,1222,1234],"patients":[8,78],"with":[9,79,233,703,1354,1378],"acetylcholine":[10],"receptor":[11],"autoantibody":[12],"positive":[13],"(AChR":[14],"Ab+)":[15],"generalized":[16],"myasthenia":[17],"gravis":[18],"(gMG),":[19],"stratified":[20],"to":[21,102,132,159,400,713,911,1363,1388],"specific":[22],"disease":[23,136,147,262],"characteristics.":[24],"Background:":[25],"RAISE":[26],"(NCT04115293)":[27],"was":[28,120,177,247],"a":[29,38,242,284,302,320,338,356,374,392,416,434,453,471,495,519,603,621,639,657,700,732,759,786,838,856,896,927,1016,1041,1066,1091,1115,1143,1170,1195,1343,1347,1371,1375],"Phase":[30],"3,":[31],"multicenter,":[32],"double-blind,":[33],"placebo-controlled":[34],"study":[35],"zilucoplan,":[37],"macrocyclic":[39],"peptide":[40],"inhibitor":[41],"complement":[43],"C5,":[44],"that":[45,1360,1385],"resulted":[46],"statistically":[48],"significant":[49],"and":[50,146,189,200,205,214,227,246,1382],"clinically":[51],"meaningful":[52],"improvement":[53],"MG-related":[55],"endpoints":[57],"(primary":[58],"endpoint:":[59],"MG-ADL":[60,93,126,138,172],"score;":[61],"LS":[62],"mean":[63,169],"change":[64],"from":[65,538,549,560,571,579,587,670,682,805,819,875,955,1246,1258,1270,1285,1296,1312,1325,1337],"baseline":[66,135,183,194],"[CFB]":[67],"zilucoplan:":[69],"\u22124.39":[70],"vs":[71,175,187,192,198,203,212,218,235],"placebo":[72,112,163,176],"\u22122.30,":[73],"difference":[74],"\u22122.09,":[75],"p<0.001),":[76],"AChR":[80,91],"Ab+":[81],"gMG.":[82],"Design/Methods:":[83],"Adult":[84,701],"participants":[85,156],"(MGFA":[86],"Disease":[87,1299],"Class":[88],"II\u2013IV":[89],"gMG,":[90],"Ab+,":[92],"score":[94,97],"\u22656,":[95],"QMG":[96,142,226],"\u226512)":[98],"were":[99,129,157,229],"randomized":[100,158],"1:1":[101],"daily":[103],"subcutaneous":[104,251],"doses":[105],"0.3":[108],"mg/kg":[109],"or":[110,140,144,150,162,264,474,498,522,735,762,789,859,951,1019,1044,1069,1094,1118,1146,1173,1366,1391],"matched":[111],"for":[113,173,225,281,286,299,304,317,322,335,340,353,358,371,376,389,394,413,418,431,436,450,455,468,479,492,503,516,527,600,605,618,623,636,641,654,659,697,729,740,756,767,783,794,835,840,853,864,893,899,924,929,938,964,985,1013,1024,1038,1049,1063,1074,1088,1099,1112,1123,1140,1151,1167,1178,1192,1198,1298],"12":[114,124,224],"weeks.":[115],"The":[116,529,540,551,562,661,673,715,742,769,796,810,866,1237,1249,1261,1276,1287,1303,1316,1328],"primary":[117],"endpoint":[119],"CFB":[121,170,221],"at":[122,222],"Week":[123,166,223],"score.":[127],"Subgroups":[128],"pre-specified":[130],"according":[131],"following":[134],"characteristics:":[137],"\u22649":[139],"\u226510,":[141],"\u226417":[143],"\u226518,":[145],"duration":[148,206],"<5":[149,209],"\u22655":[151,215],"years.":[152],"Results:":[153],"Overall,":[154],"174":[155],"(n=86)":[161],"(n=88).":[164],"At":[165],"12,":[167],"consistently":[178,231],"improved":[179,232],"each":[181],"subgroup:":[182],"MG-ADL:":[184],"\u22649:":[185],"\u22123.88":[186],"\u22122.48":[188],"\u226510:":[190],"\u22125.24":[191],"\u22123.06;":[193],"QMG:":[195],"\u226417:":[196],"\u22124.19":[197],"\u22122.81":[199],"\u226518:":[201],"\u22125.11":[202],"\u22122.88;":[204],"disease:":[208],"years:":[210,216],"\u22123.92":[211],"\u22123.04":[213],"\u22125.38":[217],"\u22122.62.":[219],"Mean":[220],"MGC":[228],"also":[230],"placebo,":[236],"across":[237],"all":[238],"subgroups.":[239],"Zilucoplan":[240],"showed":[241],"favorable":[243],"safety":[244],"profile":[245],"well-tolerated.":[248],"Conclusions:":[249],"Daily":[250],"demonstrated":[253],"consistent":[254],"improvements":[255],"MG-specific":[257],"outcomes":[259],"irrespective":[260],"severity":[263],"duration.":[265],"Funding:":[266],"UCB":[267,437,820,944,991,1000,1127,1274],"Pharma.":[268,438,823,992,1001],"Disclosure:":[269],"Dr.":[270,288,306,324,342,360,378,396,402,420,439,457,481,505,532,543,554,565,573,581,589,607,625,643,664,676,686,718,745,772,799,813,824,842,869,907,913,932,946,958,971,1002,1027,1052,1077,1101,1129,1156,1181,1201,1209,1218,1230,1240,1252,1264,1279,1290,1306,1319,1331,1340,1368],"Weiss":[271,289,307,325,343,361,379],"has":[272,290,308,326,344,362,380,398,404,422,441,459,483,507,534,545,556,567,575,583,591,609,627,645,666,678,688,711,720,747,774,801,815,826,844,871,884,909,915,934,948,960,973,981,997,1004,1029,1054,1079,1103,1131,1158,1183,1203,1211,1220,1232,1242,1254,1266,1281,1292,1308,1321,1333,1342,1370],"received":[273,291,309,327,345,363,381,405,423,442,460,484,508,535,546,557,568,576,584,592,610,628,646,667,679,689,721,748,775,802,816,827,845,872,885,916,935,949,961,982,1005,1030,1055,1080,1104,1132,1159,1184,1243,1255,1267,1282,1293,1309,1322,1334],"personal":[274,292,310,328,346,364,382,406,424,443,461,485,509,593,611,629,647,690,722,749,776,828,846,886,917,936,962,983,1006,1031,1056,1081,1105,1133,1160,1185],"compensation":[275,293,311,329,347,365,383,407,425,444,462,486,510,594,612,630,648,691,723,750,777,829,847,887,918,937,963,984,1007,1032,1057,1082,1106,1134,1161,1186],"range":[278,296,314,332,350,368,386,410,428,447,465,489,513,597,615,633,651,694,726,753,780,832,850,890,921,1010,1035,1060,1085,1109,1137,1164,1189],"$5,000-$9,999":[280,696,782,1139],"serving":[282,300,318,336,354,372,390,414,432,451,469,493,517,601,619,637,655,698,730,757,784,836,854,894,925,939,965,986,1014,1039,1064,1089,1113,1141,1168,1193],"as":[283,301,319,337,355,373,391,415,433,452,602,620,638,656,699,837,926,940,966,987,1346,1374],"Consultant":[285,303,321,339,357,375,393,417,435,454,604,622,640,658,839,928],"UCB-RA.":[287],"$500-$4,999":[298,316,352,370,388,412,430,449,467,491,515,599,617,635,653,728,755,834,852,1087,1166],"Biogen.":[305,377],"Argenx.":[323,419,795],"$10,000-$49,999":[334,923,1012,1037,1062,1111,1191],"Alexion.":[341,456],"Amylyx.":[359],"Soleo.":[395],"Bresch":[397],"nothing":[399,712,910],"disclose.":[401,714,912],"Freimer":[403,421,440,458,482,506,533,544,555,566,574,582],"on":[470,494,518,731,758,785,855,895,1015,1040,1065,1090,1114,1142,1169,1194],"Scientific":[472,496,520,733,760,787,857,1017,1042,1067,1092,1116,1144,1171,1348],"Advisory":[473,497,521,734,761,788,858,1018,1043,1068,1093,1117,1145,1172],"Data":[475,499,523,736,763,790,860,1020,1045,1070,1095,1119,1147,1174],"Safety":[476,500,524,737,764,791,861,1021,1046,1071,1096,1120,1148,1175],"Monitoring":[477,501,525,738,765,792,862,1022,1047,1072,1097,1121,1149,1176],"board":[478,502,526,739,766,793,863,1023,1048,1073,1098,1122,1150,1177],"argenx.":[480],"ra.":[504],"immunovant.":[528],"institution":[530,541,552,563,662,674,716,743,770,797,811,867,1238,1250,1262,1277,1288,1304,1317,1329],"research":[536,547,558,569,577,585,668,680,803,817,873,1244,1256,1268,1283,1294,1310,1323,1335],"support":[537,548,559,570,578,586,669,681,804,818,874,1245,1257,1269,1284,1295,1311,1324,1336],"Alnylum.":[539],"UCB.":[550,606,741,841,865,970,976],"NIH.":[561,1286],"Janssen.":[572],"Avidity.":[580],"Fulcrum.":[588],"Hewamadduma":[590,608,626,644,665,677,687],"ARENX.":[624],"BIOGEN.":[642],"ROCHE.":[660],"Neurocare":[671],".":[672],"Sheffield":[683],"Charitable":[684],"Trust.":[685],"Expert":[702],"National":[704],"Health":[705],"Service":[706],"England":[707],"(NHSE).":[708],"Raul":[709],"Juntas-Morales":[710],"Leite":[719,746,773,800,814],"Viela/Horizon.":[768],"Non-Profit":[806],"Organization":[807],"-":[808,821],"Myaware.":[809],"Ra":[822,1124,1271],"Maniaol":[825,843,870],"ALS":[876],"patient":[877],"organization":[878],"Alltid":[879],"litt":[880],"sterkere.":[881],"Masayuki":[882],"Masuda":[883],"$0-$499":[892],"Speakers":[897,1196],"Bureau":[898,1197],"Alexion":[900,1075,1247],"pharma,":[901,903],"Argenix":[902],"Aasahi":[904],"kasei":[905],"pharma.":[906],"Sivakumar":[908],"Zajda":[914],"Signant":[930],"Health.":[931],"Boroojerdi":[933,947],"an":[941,952,967,988],"employee":[942,968,989],"Biosciences.":[945,957],"stock":[950,974,998,1204,1212,1221,1233],"ownership":[953],"interest":[954],"UCb":[956],"Duda":[959,972],"Mrs.":[977,993],"De":[978,994],"La":[979,995],"Borderie":[980,996],"Howard":[1003,1028,1053,1078,1102,1130,1157,1182,1202,1210,1219,1231,1241,1253,1265,1280,1291,1307,1320,1332,1341,1369],"arenx":[1025],"BVBA.":[1026,1260],"Regeneron":[1050],"Pharmaceuticals.":[1051,1076,1248,1327],"Immunivant.":[1100],"Pharma":[1125,1272],"(now":[1126,1273],"Biosciences).":[1128,1275],"Viela":[1152],"Bio":[1153],"(Horizon":[1154],"Therapeutics).":[1155],"Sanofi":[1179],"US.":[1180],"Academic":[1199],"CME.":[1200],"General":[1206],"Electric":[1207],"dividends.":[1208,1217,1224,1236],"Johnson":[1214,1216],"&":[1215],"Pfizer":[1223],"An":[1225],"immediate":[1226],"family":[1227],"member":[1228,1353,1377],"GlaxoSmithKline":[1235],"argenx":[1259],"Centers":[1297],"Control/Research":[1300],"Triangle":[1301],"Institute.":[1302],"Duke":[1313],"University":[1314],"(DCRI).":[1315],"Millenium":[1326],"Cartestian":[1338],"Therapeutics.":[1339],"non-compensated":[1344,1372],"relationship":[1345,1373],"Advisiory":[1349],"Board":[1350],"member,":[1351],"Committee":[1352,1376],"Myasthenia":[1355],"Gravis":[1356],"Foundation":[1357],"America":[1359],"is":[1361,1386],"relevant":[1362,1387],"AAN":[1364,1389],"interests":[1365,1390],"activities.":[1367,1392],"American":[1379],"Assoc":[1380],"Neuromuscular":[1381],"Electrodiagnostic":[1383],"Medicine":[1384]},"counts_by_year":[{"year":2024,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-29T00:00:00"}